학술논문
Noninvasive Surrogate Markers of Pulmonary Hypertension Are Associated with Poor Survival in Patients with Lung Cancer.
Document Type
letter
Author
Source
American Journal of Respiratory & Critical Care Medicine; 5/15/2021, Vol. 203 Issue 10, p1316-1319, 4p
Subject
Language
ISSN
1073449X
Abstract
The article presents a retrospective analysis of the prevalence of computed tomography (CT) surrogate markers for pulmonary hypertension and their impact on survival in patients with lung cancer. It mentions that individuals with lung cancer frequently have comorbidities, including chronic obstructive pulmonary disease (COPD) and cardiovascular disease.